LIC Sells Over Two per cent Stake in Sun Pharma for Rs 4,699 Cr

Last edition

LIC Sells Over Two per cent Stake in Sun Pharma for Rs 4,699 Cr

LIC has sold two per cent of its holding in Sun Pharma for Rs 4,699 crore via open market sale.

“Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 per cent to 3.012 per cent of the paid-up capital of the said company,” said LIC in a regulatory filing.

It also informed that the shares were sold at an average price of Rs 973.80 per share.

Read more on:

More news about: global pharma | Published by Manvi | September - 19 - 2023 | 662

Last news about this category

Onco-Innovations Subsidiary Partners with GSK on Real-World Oncology Data Research

Cellenkos Receives US FDA IND Clearance for CK0802 Phase 1b/ 2a Trial in GVHD

Incyte Wins US FDA Approval for Jakafi XR (Ruxolitinib)

Arrowhead Pharmaceuticals Wins Australia TGA Approval for REDEMPLO

China's Center of Drug Evaluation Accepts Marketing Authorisation Application for Bayer's FXIa Inhibitor

Pfizer Reaches Three Settlement Deals for VYNDAMAX

US FDA Approves Regeneron's Otarmeni, First Gene Therapy for Genetic Hearing Loss

AbbVie Provides US Regulatory Update on TrenibotE BLA

Integrated DNA Technologies Expands Manufacturing Capacity to Boost Cancer Research Solutions

Syntegon Posts Record Year in 2025 and Aims for Further Growth

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy